ATE482723T1 - Halbfeste mukoadhäsive formulierungen - Google Patents

Halbfeste mukoadhäsive formulierungen

Info

Publication number
ATE482723T1
ATE482723T1 AT04742064T AT04742064T ATE482723T1 AT E482723 T1 ATE482723 T1 AT E482723T1 AT 04742064 T AT04742064 T AT 04742064T AT 04742064 T AT04742064 T AT 04742064T AT E482723 T1 ATE482723 T1 AT E482723T1
Authority
AT
Austria
Prior art keywords
semi
mucoadhesive formulations
solid
solid mucoadhesive
formulations
Prior art date
Application number
AT04742064T
Other languages
English (en)
Inventor
Fern Ndez Lvaro Acebran
Garcoea Ana Campuzano
Ndez Martin Rosa Maria Hern
Olaechea Manuela Igartua
Munoz Jose Luis Pedraz
Gascan Alicia Rodroeguez
Original Assignee
Italfarmaco Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Sa filed Critical Italfarmaco Sa
Application granted granted Critical
Publication of ATE482723T1 publication Critical patent/ATE482723T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Adhesive Tapes (AREA)
AT04742064T 2003-07-16 2004-07-16 Halbfeste mukoadhäsive formulierungen ATE482723T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301672A ES2237298B1 (es) 2003-07-16 2003-07-16 Formulaciones mucoadhesivas semisolidas.
PCT/ES2004/000336 WO2005007194A1 (es) 2003-07-16 2004-07-16 Formulaciones mucoadhesivas semisólidas

Publications (1)

Publication Number Publication Date
ATE482723T1 true ATE482723T1 (de) 2010-10-15

Family

ID=34072910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04742064T ATE482723T1 (de) 2003-07-16 2004-07-16 Halbfeste mukoadhäsive formulierungen

Country Status (13)

Country Link
US (1) US8663688B2 (de)
EP (2) EP1652535B1 (de)
JP (1) JP4891765B2 (de)
AT (1) ATE482723T1 (de)
CY (1) CY1110954T1 (de)
DE (1) DE602004029369D1 (de)
DK (1) DK1652535T3 (de)
ES (2) ES2237298B1 (de)
HR (1) HRP20100635T1 (de)
PL (1) PL1652535T3 (de)
PT (1) PT1652535E (de)
SI (1) SI1652535T1 (de)
WO (1) WO2005007194A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
AU2004274000B2 (en) 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
CN101232869B (zh) * 2005-06-16 2016-03-02 沃纳奇尔科特有限责任公司 局部给药的凝胶组合物
EP1904028A1 (de) * 2005-06-16 2008-04-02 Warner Chilcott Company Inc. Östrogenzusammensetzungen zur vaginalen verabreichung
EP1896078A1 (de) * 2005-06-16 2008-03-12 Warner Chilcott Company, Inc. Östrogenzusammensetzungen zur vaginalen verabreichung
MX2008001687A (es) * 2005-08-12 2008-02-19 Drugtech Corp Composiciones de estrogenos y metodos terapeuticos de uso.
WO2007085020A2 (en) * 2006-01-20 2007-07-26 Pear Tree Pharmaceuticals, Inc. Method of treating atrophic vaginitis
LT2018164T (lt) * 2006-05-12 2017-07-10 Christian Noe Vaistų derinių, apimančių priešgrybelinius agentus, naudojimas
BRPI0711525A2 (pt) * 2006-06-02 2011-11-01 Pear Tree Women S Health Care composição farmacêutica e método para tratar sintomas de vaginite atrófica
WO2008005783A2 (en) * 2006-06-30 2008-01-10 Drugtech Corporation Treatment of non- infectious inflammatory vulvovaginitis with a bioadhesive clindamycin composition
ES2310968B1 (es) * 2007-06-25 2010-02-08 Italfarmaco, S.A. Uso de estriol en bajas dosis.
ES2344673B1 (es) * 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
AU2009281998A1 (en) * 2008-08-12 2010-02-18 Novabay Pharmaceuticals, Inc. Antimicrobial gel formulations
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
ES2344675B1 (es) * 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
AU2011234492B2 (en) * 2010-04-01 2014-02-27 Palette Life Sciences AB Thermogelling anaesthetic compositions
CN102293735B (zh) * 2011-08-19 2013-05-01 辽宁万嘉医药科技有限公司 一种抗真菌咪唑类药物缓释凝胶和制备方法
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN102600288B (zh) * 2012-04-20 2014-03-05 广西源安堂药业有限公司 一种治疗阴道炎的复方黄松凝胶药物及其制备方法
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
KR101358993B1 (ko) 2012-09-05 2014-02-06 임혜선 네일 프린팅용 트랜스퍼 솔루션 및 이를 이용한 네일 프린팅 방법
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (de) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und therapien
RU2016141135A (ru) 2014-07-29 2018-08-28 Терапьютиксмд, Инк. Трансдермальный крем
US20160175271A1 (en) * 2014-12-19 2016-06-23 Gavis Pharmaceuticals Rectal suppository for ulcerative colitis
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
MX393613B (es) * 2016-01-07 2025-03-24 Viramal Ltd Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
AU2019365255B2 (en) 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
EP3659583B1 (de) 2018-11-30 2023-06-07 Viramal Limited Verfahren zur herstellung eines geliermittels, das dadurch erhaltene geliermittel und verwendung dieses geliermittels
CN110151680A (zh) * 2019-04-10 2019-08-23 重庆医药高等专科学校 雌三醇凝胶产品及制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0163696B1 (de) 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Verwendung eines bioadhesives
NZ222698A (en) 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE69014081T2 (de) 1989-10-31 1995-03-30 Columbia Laboratories, Inc., Miami, Fla. Mittel zur Feuchthaltung vaginalen Gewebes.
MC2204A1 (fr) 1989-10-31 1992-11-26 Columbia Lab Inc Composition et methode d'humidification de tissus
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
AT408067B (de) 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
AU714797B2 (en) 1996-06-14 2000-01-13 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes, methods of making and use thereof
IT1284874B1 (it) 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
US5942243A (en) 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
DE69739583D1 (de) 1996-11-14 2009-10-29 Lipomedica Ehf Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6159491A (en) 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
WO2000050078A1 (en) 1999-02-26 2000-08-31 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
SE522260C2 (sv) 1999-10-01 2004-01-27 Ericsson Telefon Ab L M Metod, system och säkerhetsadapter för att exekvera säker dataöverföring i ett trådlöst nät
UA74168C2 (uk) 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
WO2001028515A1 (en) * 1999-10-22 2001-04-26 Líf-Hlaup ehf. Bio-Gels Pharmaceuticals Inc. Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
ATE485837T1 (de) * 2000-08-03 2010-11-15 Antares Pharma Ipl Ag Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US6967194B1 (en) * 2002-09-18 2005-11-22 Susan Matsuo Bio-identical hormones and method of use
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.

Also Published As

Publication number Publication date
JP4891765B2 (ja) 2012-03-07
WO2005007194A1 (es) 2005-01-27
EP1652535A1 (de) 2006-05-03
US8663688B2 (en) 2014-03-04
SI1652535T1 (sl) 2010-12-31
HRP20100635T1 (hr) 2010-12-31
ES2353694T3 (es) 2011-03-04
DE602004029369D1 (de) 2010-11-11
EP1652535B1 (de) 2010-09-29
EP2100612A2 (de) 2009-09-16
PT1652535E (pt) 2010-11-18
EP2100612A3 (de) 2010-06-02
CY1110954T1 (el) 2015-06-11
DK1652535T3 (da) 2010-11-15
US20060240111A1 (en) 2006-10-26
PL1652535T3 (pl) 2011-03-31
JP2007528864A (ja) 2007-10-18
ES2237298B1 (es) 2006-11-01
ES2237298A1 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
ATE482723T1 (de) Halbfeste mukoadhäsive formulierungen
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
MA27888A1 (fr) Inhibiteurs de la kinase p38 a base d'heterocycles a 5 chainons
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
WO2003014309A3 (en) Interleukin-1 receptors in the treatment of diseases
ATE407676T1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
NO20034056D0 (no) Proliferative sykdommer
IL181740A0 (en) THERAPEUTIC AGENTS TARGETING THE NCca-atp CHANNEL AND METHODS OF USE THEREOF
WO2006034048A3 (en) Therapeutic agents targeting the ncca-atp channel and methods of use thereof
TR200800691T2 (tr) Miyelin kaybettiren hastalıkların ya da durumların tedavi yöntemi.
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
BR0210632A (pt) Tratamento de doença parasìtica
SE0001916D0 (sv) Novel formulation
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
DK1713438T3 (da) Medicinsk sæbe
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
WO2002051404A8 (fr) Compositions orales
RU2000104127A (ru) Штамм bacillus subtilis x-15, используемый для профилактики и лечения эндометритов у коров
WO2004006900A3 (en) Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases
ITBO20000360A0 (it) Apparecchiatura di elettrostimolazione del corpo umano .
DE602004010353D1 (de) Aktiviebare bioaktive implantierbare medizinische Vorrichtung.
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
WO2002083110A3 (en) Animal model for evaluating analgesics

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1652535

Country of ref document: EP